Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Franklin Biolabs is a preclinical CRO for genetic medicines, biologics, and cell and gene therapies—not a typical SaaS or enterprise software product. The website emphasizes that it can support programs from the discovery stage through IND and even commercialization. Its clients include global biotech and pharma companies as well as academic institutions, and it states that it has served 1,000+ customers across 30+ countries.
Its business is mainly divided into three areas: Vector | CMC | Analytics, Preclinical | Translational, and Bioanalytics. The first covers AAV research vector production, expanded adenovirus/lentivirus services, DNA services, process development, large-scale AAV manufacturing, as well as NGS, particle characterization, titer, mass spectrometry, potency, residuals, and custom analytical methods. The preclinical module provides in vivo studies, animal models, routes of administration, surgery and imaging, neurobehavioral assessment, GLP/non-GLP toxicology, pathology, and digital workflows. The bioanalytics module focuses on immunogenicity, biodistribution, viral shedding, and biomarker detection.
The website does not disclose standard packages, unit pricing, or a subscription model, making it more consistent with project-based/custom quotes. Routine research vector orders are said to take about 3–4 weeks to deliver, while custom designs may take up to 8 weeks. Plasmid generation and cloning may add another 2–3 weeks.
Its strengths are its comprehensive vertical capabilities, covering both vector manufacturing and GLP studies, QA oversight, and regulatory filing support. It also offers extensive AAV experience, broad serotype coverage, and a wide range of QC options, while emphasizing ongoing communication and technical support. The drawback is that it is not a software product, so it lacks SaaS evaluation elements such as APIs, permissions, third-party system integrations, cloud deployment, and data security certifications. Pricing, SLAs, and standard service boundaries are also not publicly disclosed.
It is suitable for R&D teams looking to advance AAV/cell and gene therapy programs from candidate screening to pre-IND studies, especially organizations that want to outsource vector work, toxicology, pathology, and bioanalysis to a single provider. Access from mainland China cannot be determined from the provided text alone and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on franklinbio.com official site.
franklinbio.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach franklinbio.com directly.